Prognostic DNA methylation marker in serum of cancer patients

Annals of the New York Academy of Sciences

Volumn 1022, Issue , 2004, Pages 44-49

  Müller, Hannes M ^a   Fiegl, Heidi ^a   Widschwendter, Andreas ^a   Widschwendter, Martin ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Breast cancer; Cervical cancer; DNA methylation; Prognosis; Serum

Indexed keywords

DNA;

BREAST CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; EVALUATION; FEMALE; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; METHYLATION; MOLECULAR DYNAMICS; PROGNOSIS; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA;

EID: 3242722057     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1318.008     Document Type: Conference Paper

References (15)

1. JONES, P.A. & S.B. BAYLIN. 2002. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3: 415-428.
2. LAIRD, P.W. 2003. Early detection: the power and the promise of DNA methylation markers. Nat. Rev. Cancer 3: 253-266.
3. ANKER, P. et al. 1999. Detection of circulating tumour DNA in the blood (plasma/ serum) of cancer patients. Cancer Metastasis Rev. 18: 65-73.
4. MÜLLER, H.M. & M. WIDSCHWENDTER. 2003. Methylated DNA as a possible screening marker for neoplastic disease in several body fluids. Expert. Rev. Mol. Diagn. 3: 443-458.
5. WIDSCHWENDTER, A. et al. 2004. DNA methylation in serum and tumors of cervical cancer patients. Clin. Cancer Res. 10: 565-571.
6. MÜLLER, H.M. et al. 2003. DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res. 63: 7641-7645.
7. WIDSCHWENDTER, A. et al. 2004. CDH1 and CDH13 Methylation in serum is an independent prognostic marker in cervical cancer patients. Int. J. Cancer. 109: 163-166.
8. EADS, C. A. et al. 2001. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 61: 3410-3418.
9. EADS, C.A. et al. 2000. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28: E32.
10. ISSA, J.P. et al. 2001. Accelerated age-related cpg island methylation in ulcerative colitis. Cancer Res. 61: 3573-3577.
11. NAKAGAWA, H. et al. 2001. Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite- unstable colorectal cancer development. Cancer Res. 61: 6991-6995.
12. HABUCHI, T. et al. 2001. Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer. Oncogene 20: 531-537.
13. LEON, S.A. et al. 1977. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37: 646-650.
14. KLEIN, C.A. et al. 2002. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360: 683-689.
15. GARCIA-OLMO, D. & D.C. GARCIA-OLMO. 2001. Functionality of circulating DNA: the hypothesis of genometastasis. Ann. N.Y. Acad. Sci. 945: 265-275.